Recombinant Activated Factor VII: Treating Postoperative Hemorrhage in Cardiac Surgery
- 31 March 2006
- journal article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 81 (3) , 875-879
- https://doi.org/10.1016/j.athoracsur.2005.09.003
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Hemorrhage After Coronary Artery Bypass Graft ProceduresInfection Control & Hospital Epidemiology, 2003
- Use of Recombinant Factor VIIa in 3 Patients with Inherited Type I Glanzmann’s Thrombasthenia Undergoing Invasive ProceduresThrombosis and Haemostasis, 2000
- Clinical Use of Recombinant FVIIa (rFVIIa)Transfusion Science, 1998
- Reexploration for Hemorrhage Following Coronary Artery Bypass GraftingIncidence and Risk FactorsArchives of Surgery, 1998
- The Epidemiology of Hemorrhage Related to Cardiothoracic OperationsInfection Control & Hospital Epidemiology, 1998
- The platelet function defect of cardiopulmonary bypass [see comments]Blood, 1993
- Bleeding complications associated with cardiopulmonary bypassBlood, 1990
- Determinants of hospital charges for coronary artery bypass surgery: The economic consequences of postoperative complicationsThe American Journal of Cardiology, 1990
- Mediastinal bleeding after cardiac surgery: Etiologies, diagnostic considerations, and blood conservation methodsJournal of Cardiothoracic Anesthesia, 1989
- SUCCESSFUL USE OF RECOMBINANT FACTOR VIIa IN PATIENT WITH SEVERE HAEMOPHILIA A DURING SYNOVECTOMYThe Lancet, 1988